NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Bradley LA, Palomaki G, Gutman S, et al. PCA3 Testing for the Diagnosis and Management of Prostate Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. (Comparative Effectiveness Reviews, No. 98.)
This publication is provided for historical reference only and the information may be out of date.
Figure 9Distributions of PCA3 and tPSA in men with positive and negative prostate biopsies from four studies that reported such information in the same cohort
PCA3 = prostate cancer antigen 3 gene; tPSA = total prostate specific antigen
Note: The logarithmic means and pooled standard deviations were obtained from Table 11. The solid line indicates the distribution for those with a negative biopsy, while the dashed line represents the distribution in those with a positive biopsy. For each study (indicated by the first author), these distributions were obtained in the same group of men. The figures are sorted by the relative performance of PCA3 over tPSA (from left to right, top to bottom).
- Figure 9, Distributions of PCA3 and tPSA in men with positive and negative prost...Figure 9, Distributions of PCA3 and tPSA in men with positive and negative prostate biopsies from four studies that reported such information in the same cohort - PCA3 Testing for the Diagnosis and Management of Prostate Cancer
Your browsing activity is empty.
Activity recording is turned off.
See more...